4.8 out of 5 stars
(6 Ratings)
Access your bank's or credit union's financial performance from anywhere, anytime. Secure, cloud-based access gives you insight into your bank's financial performance. With a few clicks, you can access margin components, branch performance, forecasts, and more. The Banker's Dashboard and Credit Union Dashboard integrate seamlessly with your core processor. Easy setup allows you to immediately improve your bottom line. Automate reporting and eliminate errors so you can focus on higher-value tasks. Multiple forecast scenarios can be quickly run and revised, allowing you to analyze variances and other strategies. Compare branch performance. For better results, institute best practices and hold branches accountable.
Learn more about Banker's Dashboard

Dun & Bradstreet’s ChatD&B offers a powerful, AI-driven chat interface that simplifies how organizations research and assess companies. Instead of traditional complex filtering, users interact naturally by asking questions in their own words to receive tailored insights such as company financials, risk scores, and market data. The platform taps into the vast Dun & Bradstreet Data Cloud to deliver real-time, reliable information that supports smarter, faster business decisions. Enhanced features include visibility into the data sources behind results, chat history for audit trails, and quick answers to product-related queries. ChatD&B is designed to optimize workflows across sales, finance, and risk management by providing instant access to trusted company data. It helps teams discover new opportunities, evaluate customers, and make confident decisions all through easy chat conversations. The platform also enables better compliance and verification by allowing users to track and reference past interactions. With ChatD&B, organizations can accelerate growth and reduce operational friction.
Learn more about ChatD&B
BioSniper
BioSniper serves as a research platform tailored for equity analysts, investors, and professionals in the life sciences sector. Users can articulate their research or investment ideas in straightforward language, and the platform then organizes this input into a systematic workflow that includes various screenings, checks by specialized agents, scoring mechanisms, blocking protocols, and gates for evidence. It conducts searches across seven categories of public sources, which encompass SEC EDGAR filings along with insider trading data, FDA-related events, ClinicalTrials.gov, PubMed, USPTO and Google Patents, biotech news, and market analytics. The platform ensures that findings are linked to their source records, with any gaps or discrepancies in evidence flagged as unknown instead of making assumptions; it also provides the source and applicable dates when they are available. Furthermore, BioSniper includes a complimentary public calendar for biotech events, an SEC cash runway calculator, and an open-source toolkit in Python for users to leverage. In addition to these features, the platform aims to enhance the decision-making process for its users by providing comprehensive access to relevant data.
Learn more about BioSniper
FN2
FN2 functions as an independent stock decision-making engine, designed to relieve you from the repetitive daily research tasks. Rather than engaging in the same research cycle each morning, FN2 employs AI agents that actively monitor the markets, conduct in-depth research according to a set schedule, and send their findings directly to your Inbox, Phone, or Discord.
You can express your tracking preferences in plain language, whether it's a specific ticker, a sector, a particular thesis, or a question like "notify me when NVDA's guidance changes," or you can select from a range of pre-configured agents. FN2 then transforms your input into an autonomous research agent that operates on your timeline—be it before market open, immediately following earnings reports, or on a weekly basis. Each agent meticulously analyzes earnings-call transcripts, retrieves macroeconomic data from FRED, evaluates tickers, creates visual charts, and synthesizes all this information to provide you with a decision-ready summary instead of just a collection of raw data. This means no more juggling multiple tabs, no reliance on screeners, and no need to conduct manual morning research. FN2 is specifically designed for dedicated individual investors and analysts who find themselves overwhelmed by the sheer volume of tabs, transcripts, and screeners resulting from repetitive daily tasks. By streamlining the research process, FN2 allows you to focus on making informed investment decisions with greater efficiency and ease.
Learn more about FN2